Carcinoma: all 6,718 studies
Page 50 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung CancerCompletedNCT02410603
- To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma TumorsTerminatedNCT02410174Phase 1
- Octreotide LAR as Maintenance Treatment for Patients With NECStatus unknownNCT02409849Phase 2
- EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision WoundsCompletedNCT02409628Not applicable
- An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma SubjectsCompletedNCT02409524Phase 2
- Perfusion-Induced Hyperthermia for Metastatic CarcinomaCompletedNCT02409108Not applicable
- PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare ProvidersCompletedNCT02408406Not applicable
- Assessing Uterine Ultrasound Done as a Diagnostic Tool for the Depth of Carcinoma InvasionCompletedNCT02407535Not applicable
- Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone MetsCompletedNCT02406521Phase 1
- Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCCWithdrawnNCT02406508Phase 2
- Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular CarcinomaStatus unknownNCT02403544Phase 1
- Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal CarcinomaCompletedNCT02402842Phase 2
- Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical PrognosisStatus unknownNCT02401763
- Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02400788Phase 1/2
- Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorTerminatedNCT02400424Not applicable
- Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver TransplantationStatus unknownNCT02399735Phase 1
- Perioperative Chemotherapy With Bevacizumab for Colorectal CarcinomatosisCompletedNCT02399410Phase 2
- Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal CarcinomaCompletedNCT02399306Phase 3
- Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After HepatectomyStatus unknownNCT02399033Phase 4
- A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.Status unknownNCT02398552Phase 2
- Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular CarcinomaCompletedNCT02395523Not applicable
- The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized TrialCompletedNCT02394652Phase 2
- Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland CarcinomaCompletedNCT02393820Phase 2
- Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in SituStatus unknownNCT02389699Not applicable
- LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial CarcinomaCompletedNCT02387645Not applicable
- A Study of rSIFN-co in Subjects With Advanced Solid TumorsCompletedNCT02387307Phase 1
- A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT02386111Phase 1
- Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell CarcinomaStatus unknownNCT02384811Phase 2
- Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinCompletedNCT02381535Phase 1
- Safety Study of SEA-CD40 in Cancer PatientsTerminatedNCT02376699Phase 1
- Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric CancerStatus unknownNCT02375997Phase 3
- A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)CompletedNCT02371967
- A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemCompletedNCT02370303
- Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast CancerCompletedNCT02370277
- Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard RadiochemotherapyStatus unknownNCT02369939Phase 3
- Improved Method of Detecting Cancer MetastasesStatus unknownNCT02368067Not applicable
- Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal CancerCompletedNCT02365844
- A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorTerminatedNCT02365662Phase 1
- Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal CarcinomasCompletedNCT02364024
- Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)CompletedNCT02363751Phase 2
- Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal CarcinomaCompletedNCT02360501Phase 2
- A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular CarcinomaCompletedNCT02358395Phase 1
- Epidemiologic Study of Hepatocellular Carcinoma in the USCompletedNCT02358070
- CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health CentersCompletedNCT02355262
- A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT02354898Phase 1
- Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)CompletedNCT02354261Phase 2
- A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusStatus unknownNCT02353936Phase 2
- Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver FunctionCompletedNCT02352935Not applicable
- Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck CancerStatus unknownNCT02352792Not applicable
- Skin Cancer Screening Education StudyStatus unknownNCT02352428Not applicable
- Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine AnaloguesCompletedNCT02351128Phase 2
- Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck CancerCompletedNCT02350712Phase 1
- A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian CancerCompletedNCT02344095Phase 1
- Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma PatientCompletedNCT02338700Phase 1/2
- Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)TerminatedNCT02338570Phase 4
- Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCCStatus unknownNCT02338297Phase 3
- A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsCompletedNCT02335918Phase 1/2
- Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.CompletedNCT02334709Phase 1/2
- Ganetespib Window of Opportunity Study in Head and Neck CancersTerminatedNCT02334319Phase 1
- Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the GallbladderCompletedNCT02332551Not applicable
- Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral CavityTerminatedNCT02331875Phase 1/2
- Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer PatientsStatus unknownNCT02330783Phase 2
- Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal CarcinomaStatus unknownNCT02328716Phase 3
- A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal CarcinomaStatus unknownNCT02328261Phase 2
- Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial CarcinomaCompletedNCT02326909Not applicable
- Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell CarcinomaCompletedNCT02326558Not applicable
- Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal CancerStatus unknownNCT02325986Phase 2
- PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic AgentsTerminatedNCT02325349Phase 2
- Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC PatientsStatus unknownNCT02324803Phase 2
- Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver CancerTerminatedNCT02323906Phase 1
- A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCCTerminatedNCT02323360Not applicable
- Same-day Versus Separate-day Preoperative Consultation for Mohs SurgeryWithdrawnNCT02321982Not applicable
- Treating Peritoneal Carcinomatosis With PIPACCompletedNCT02320448Phase 2
- Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
- Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung CancerCompletedNCT02318771Phase 1
- Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing SurgeryCompletedNCT02315469
- Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)Status unknownNCT02311205Phase 2
- Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the PancreasWithdrawnNCT02310971Phase 2
- Spanish Registry of Mohs SurgeryCompletedNCT02310503
- Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein ThrombosisStatus unknownNCT02309788
- Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal LoadStatus unknownNCT02308319Phase 4
- A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell CancerWithdrawnNCT02307474Not applicable
- Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver CancerWithdrawnNCT02304445Not applicable
- Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular CarcinomaTerminatedNCT02304289Phase 1
- CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure InvolvedStatus unknownNCT02303457Not applicable
- Esophagogastrectomy Versus Extended Gastrectomy in AEG IICompletedNCT02302118
- Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal CarcinomaStatus unknownNCT02301208Phase 3
- Combine TACE and RFA Versus TACE Alone for HCC With PVTTStatus unknownNCT02301091Phase 3
- RALPPS Venus ALPPS for Hepatocellular CarcinomaStatus unknownNCT02299843Not applicable
- Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT02298595Phase 1/2
- Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian CarcinomaCompletedNCT02297958
- An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate RecurrenceCompletedNCT02296970
- Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral CavityWithdrawnNCT02295540Not applicable
- A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)Active, not recruitingNCT02293980Phase 1
- Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular CarcinomaStatus unknownNCT02293850Phase 1
- Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal CarcinomaStatus unknownNCT02293356Phase 4
- Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT02290977Phase 2
- Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated RadiotherapyWithdrawnNCT02289807Not applicable
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer PatientsWithdrawnNCT02289300Phase 2
- Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the LiverCompletedNCT02288910